Marina Abramova

Marina Abramova

Auto-generated profile, based on publicly available information

Marina Abramova

Research Center of Nanobiotechnologies, Peter the Great St. Petersburg Polytechnic University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
PSPolina Selkova
Polina Selkova
AVAleksandra Vasileva
Aleksandra Vasileva
AAAnatolii Arseniev
Anatolii Arseniev
MAMarina Abramova
Marina Abramova
OMOlga Musharova
Olga Musharova
KSKonstantin Severinov
Konstantin Severinov
Type II CRISPR-Cas9 RNA-guided nucleases are commonly used for genome engineering. To date, all characterized Cas9-based genome editors, including the widely used SpCas9, have limitations such as their relatively large size and restriction of targets flanked by a specific PAM sequence. Here, we biochemically characterized more compact SpCas9 ortholog, SuCas9, from Streptococcus uberis , a bacterium inhabiting the mammary glands of dairy cattle. SuCas9 recognizes a novel 5′-NNAAA-3′ PAM, efficiently cleaves DNA in vitro , and is active in human cells. The study of SuCas9 has the potential to expand the range of applications of CRISPR-Cas9 enzymes in medicine and biotechnology.